Hereditary disorders of DNA repair and DNA damage tolerance that predispose to neoplastic transformation

Errol C. Friedberg, Roger A. Schultz

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Introduction Consistent with the somatic mutation theory of cancer, hereditary diseases that interfere with the functional integrity of the nuclear genome can generate an increased mutational burden in cells and hence an increased predisposition to neoplastic transformation. Multiple hereditary diseases associated with genomic instability are associated with cancer predisposition. However, some of these are extremely rare and documentation of such cancer predisposition is tenuous. This review considers some of the diseases listed in Table 36.1, all of which interfere with normal biological responses to DNA damage, or arrested or stalled DNA replication. Mouse models have been rendered for many of these human diseases, but are not discussed here in any detail. A comprehensive listing of mutant mouse strains defective in biological responses to DNA damage has been published (1). Xeroderma pigmentosum (XP) The skin cancer-prone hereditary disease xeroderma pigmentosum (XP) is the first human hereditary disease in which a definitive causal relationship was demonstrated between exposure to DNA-damaging agents and cancer predisposition. As recounted in detail elsewhere (2,3), this key observation was first documented by James Cleaver in the late 1960s, who showed that cultured cells from XP individuals are defective in the process of nucleotide excision repair (NER) and are consequently abnormally sensitive to killing following exposure to ultraviolet (UV) radiation (3).

Original languageEnglish (US)
Title of host publicationMolecular Oncology: Causes of Cancer and Targets for Treatment
PublisherCambridge University Press
Pages434-441
Number of pages8
ISBN (Print)9781139046947, 9780521876629
DOIs
StatePublished - Jan 1 2015

Fingerprint

Inborn Genetic Diseases
Xeroderma Pigmentosum
DNA Repair
DNA Damage
Neoplasms
Galium
Mutant Strains Mice
Genomic Instability
Skin Neoplasms
DNA Replication
Documentation
Cultured Cells
Observation
Genome
Radiation
Mutation
DNA

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Friedberg, E. C., & Schultz, R. A. (2015). Hereditary disorders of DNA repair and DNA damage tolerance that predispose to neoplastic transformation. In Molecular Oncology: Causes of Cancer and Targets for Treatment (pp. 434-441). Cambridge University Press. https://doi.org/10.1017/CBO9781139046947.037

Hereditary disorders of DNA repair and DNA damage tolerance that predispose to neoplastic transformation. / Friedberg, Errol C.; Schultz, Roger A.

Molecular Oncology: Causes of Cancer and Targets for Treatment. Cambridge University Press, 2015. p. 434-441.

Research output: Chapter in Book/Report/Conference proceedingChapter

Friedberg, EC & Schultz, RA 2015, Hereditary disorders of DNA repair and DNA damage tolerance that predispose to neoplastic transformation. in Molecular Oncology: Causes of Cancer and Targets for Treatment. Cambridge University Press, pp. 434-441. https://doi.org/10.1017/CBO9781139046947.037
Friedberg EC, Schultz RA. Hereditary disorders of DNA repair and DNA damage tolerance that predispose to neoplastic transformation. In Molecular Oncology: Causes of Cancer and Targets for Treatment. Cambridge University Press. 2015. p. 434-441 https://doi.org/10.1017/CBO9781139046947.037
Friedberg, Errol C. ; Schultz, Roger A. / Hereditary disorders of DNA repair and DNA damage tolerance that predispose to neoplastic transformation. Molecular Oncology: Causes of Cancer and Targets for Treatment. Cambridge University Press, 2015. pp. 434-441
@inbook{e63bb524608a4d6baddecbaf4219ff3d,
title = "Hereditary disorders of DNA repair and DNA damage tolerance that predispose to neoplastic transformation",
abstract = "Introduction Consistent with the somatic mutation theory of cancer, hereditary diseases that interfere with the functional integrity of the nuclear genome can generate an increased mutational burden in cells and hence an increased predisposition to neoplastic transformation. Multiple hereditary diseases associated with genomic instability are associated with cancer predisposition. However, some of these are extremely rare and documentation of such cancer predisposition is tenuous. This review considers some of the diseases listed in Table 36.1, all of which interfere with normal biological responses to DNA damage, or arrested or stalled DNA replication. Mouse models have been rendered for many of these human diseases, but are not discussed here in any detail. A comprehensive listing of mutant mouse strains defective in biological responses to DNA damage has been published (1). Xeroderma pigmentosum (XP) The skin cancer-prone hereditary disease xeroderma pigmentosum (XP) is the first human hereditary disease in which a definitive causal relationship was demonstrated between exposure to DNA-damaging agents and cancer predisposition. As recounted in detail elsewhere (2,3), this key observation was first documented by James Cleaver in the late 1960s, who showed that cultured cells from XP individuals are defective in the process of nucleotide excision repair (NER) and are consequently abnormally sensitive to killing following exposure to ultraviolet (UV) radiation (3).",
author = "Friedberg, {Errol C.} and Schultz, {Roger A.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1017/CBO9781139046947.037",
language = "English (US)",
isbn = "9781139046947",
pages = "434--441",
booktitle = "Molecular Oncology: Causes of Cancer and Targets for Treatment",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Hereditary disorders of DNA repair and DNA damage tolerance that predispose to neoplastic transformation

AU - Friedberg, Errol C.

AU - Schultz, Roger A.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Introduction Consistent with the somatic mutation theory of cancer, hereditary diseases that interfere with the functional integrity of the nuclear genome can generate an increased mutational burden in cells and hence an increased predisposition to neoplastic transformation. Multiple hereditary diseases associated with genomic instability are associated with cancer predisposition. However, some of these are extremely rare and documentation of such cancer predisposition is tenuous. This review considers some of the diseases listed in Table 36.1, all of which interfere with normal biological responses to DNA damage, or arrested or stalled DNA replication. Mouse models have been rendered for many of these human diseases, but are not discussed here in any detail. A comprehensive listing of mutant mouse strains defective in biological responses to DNA damage has been published (1). Xeroderma pigmentosum (XP) The skin cancer-prone hereditary disease xeroderma pigmentosum (XP) is the first human hereditary disease in which a definitive causal relationship was demonstrated between exposure to DNA-damaging agents and cancer predisposition. As recounted in detail elsewhere (2,3), this key observation was first documented by James Cleaver in the late 1960s, who showed that cultured cells from XP individuals are defective in the process of nucleotide excision repair (NER) and are consequently abnormally sensitive to killing following exposure to ultraviolet (UV) radiation (3).

AB - Introduction Consistent with the somatic mutation theory of cancer, hereditary diseases that interfere with the functional integrity of the nuclear genome can generate an increased mutational burden in cells and hence an increased predisposition to neoplastic transformation. Multiple hereditary diseases associated with genomic instability are associated with cancer predisposition. However, some of these are extremely rare and documentation of such cancer predisposition is tenuous. This review considers some of the diseases listed in Table 36.1, all of which interfere with normal biological responses to DNA damage, or arrested or stalled DNA replication. Mouse models have been rendered for many of these human diseases, but are not discussed here in any detail. A comprehensive listing of mutant mouse strains defective in biological responses to DNA damage has been published (1). Xeroderma pigmentosum (XP) The skin cancer-prone hereditary disease xeroderma pigmentosum (XP) is the first human hereditary disease in which a definitive causal relationship was demonstrated between exposure to DNA-damaging agents and cancer predisposition. As recounted in detail elsewhere (2,3), this key observation was first documented by James Cleaver in the late 1960s, who showed that cultured cells from XP individuals are defective in the process of nucleotide excision repair (NER) and are consequently abnormally sensitive to killing following exposure to ultraviolet (UV) radiation (3).

UR - http://www.scopus.com/inward/record.url?scp=84954113933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954113933&partnerID=8YFLogxK

U2 - 10.1017/CBO9781139046947.037

DO - 10.1017/CBO9781139046947.037

M3 - Chapter

AN - SCOPUS:84954113933

SN - 9781139046947

SN - 9780521876629

SP - 434

EP - 441

BT - Molecular Oncology: Causes of Cancer and Targets for Treatment

PB - Cambridge University Press

ER -